Reason: Presence of Precipitate; small amounts of diphenhydramine precipitated out of solution
Distributed: Nationwide, and one consignee in LibyaReason: Presence of Precipitate; small amounts of diphenhydramine precipitated out of solution
Distributed: Nationwide, and one consignee in LibyaReason: Marketed Without an Approved NDA/ANDA: Undeclared sibutramine and phenolphthalein in Burn 7 dietary supplement
Distributed: Puerto Rico onlyReason: Presence of Foreign Substance: Presence of stainless steel particles.
Distributed: Nationwide including Puerto Rico.Reason: Marketed Without An Approved NDA/ANDA: Product is being recalled due to excessive levels of lovastatin. Lovastatin is an FDA approved drug making this dietary supplement an unapproved new drug.
Distributed: Nationwide and Puerto RicoReason: Failed Dissolution Specifications: One lot of product is being voluntarily recalled because dissolution test results failed to meet specification throughout the product's shelf life.
Distributed: Nationwide and Puerto RicoReason: Labeling: Missing Label; The label on the immediate bottle is missing.
Distributed: Nationwide in USReason: Marketed Without an Approved NDA/ANDA: FDA analysis found the product to contain undeclared active ingredient, tadalafil, thus making these products unapproved drugs.
Distributed: Nationwide.Reason: Marketed Without an Approved NDA/ANDA: FDA analysis found the product to contain undeclared active ingredient, tadalafil, thus making these products unapproved drugs.
Distributed: Nationwide.Reason: Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.
Distributed: Nationwide and Puerto Rico